Matches in Wikidata for { <http://www.wikidata.org/entity/Q90693429> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q90693429 description "clinical trial" @default.
- Q90693429 description "ensayo clínico" @default.
- Q90693429 description "ensayu clínicu" @default.
- Q90693429 description "klinisch onderzoek" @default.
- Q90693429 description "клінічне випробування" @default.
- Q90693429 name "A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major De" @default.
- Q90693429 name "A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major De" @default.
- Q90693429 type Item @default.
- Q90693429 label "A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major De" @default.
- Q90693429 label "A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major De" @default.
- Q90693429 prefLabel "A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major De" @default.
- Q90693429 prefLabel "A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major De" @default.
- Q90693429 P1132 Q90693429-E165EBE3-1C29-49A2-B73E-D36530347650 @default.
- Q90693429 P1476 Q90693429-5A2F4421-FF7A-4F12-AD04-B75951ABDEF5 @default.
- Q90693429 P17 Q90693429-011CF5FB-906D-4826-B44C-D945294422FC @default.
- Q90693429 P17 Q90693429-03464D9A-D948-4E4A-B0CB-5DAA0103E4EA @default.
- Q90693429 P17 Q90693429-395CB260-B5C1-4938-8DFF-EEC46F9DB40B @default.
- Q90693429 P17 Q90693429-41234789-A210-4747-9EC0-C830A8A5F889 @default.
- Q90693429 P17 Q90693429-7E2727E9-9CDB-471E-BD69-F98E9F9109D8 @default.
- Q90693429 P17 Q90693429-7EE85907-F8D5-4BA0-8E71-AA59C4026AAC @default.
- Q90693429 P17 Q90693429-D1CC0F2D-54AF-41FF-8A2D-1589C1A7D6A8 @default.
- Q90693429 P17 Q90693429-E562AF7F-43E3-4D75-925D-8B35C37448AE @default.
- Q90693429 P17 Q90693429-EE2407C0-300E-4F14-9971-8D8D96359C6A @default.
- Q90693429 P17 Q90693429-F71A8F80-98D6-4269-A299-E371B7F046E9 @default.
- Q90693429 P1813 Q90693429-D012B4D8-60E9-4EC4-B734-DA428FBB0882 @default.
- Q90693429 P2899 Q90693429-962FCD52-452C-4812-BDC1-8DF962D63D14 @default.
- Q90693429 P3098 Q90693429-E985ACEC-AFC6-4AA4-84C2-E0D144CF1D79 @default.
- Q90693429 P31 Q90693429-70EE13C3-D69C-4DAF-9C72-F16C225F1926 @default.
- Q90693429 P4135 Q90693429-FDE24CBD-6C28-42B7-B443-E215E49AB239 @default.
- Q90693429 P4844 Q90693429-3AF21049-BAF5-48C1-A915-0CA76B351754 @default.
- Q90693429 P4844 Q90693429-73DAA7EF-61E9-464A-935A-90F169104E3B @default.
- Q90693429 P4844 Q90693429-D6697CEF-7D62-4470-8907-9C72A2D922AC @default.
- Q90693429 P580 Q90693429-ED5CBC74-F989-4C74-910C-8A25F7E967F0 @default.
- Q90693429 P582 Q90693429-CBF3AB4E-76C9-4AE0-A244-B6C38C393070 @default.
- Q90693429 P6099 Q90693429-5FAE340C-1632-4612-8D42-C51885D89776 @default.
- Q90693429 P8363 Q90693429-922C20AC-30DF-4294-BEFA-C93151EECCA1 @default.
- Q90693429 P1132 "+622" @default.
- Q90693429 P1476 "A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared With Quetiapine Extended-Release in Adult and Elderly Participants With Treatment-Resistant Major Depressive Disorder Who Are Continuing a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor" @default.
- Q90693429 P17 Q142 @default.
- Q90693429 P17 Q183 @default.
- Q90693429 P17 Q219 @default.
- Q90693429 P17 Q28 @default.
- Q90693429 P17 Q31 @default.
- Q90693429 P17 Q36 @default.
- Q90693429 P17 Q43 @default.
- Q90693429 P17 Q45 @default.
- Q90693429 P17 Q55 @default.
- Q90693429 P17 Q801 @default.
- Q90693429 P1813 "ESCAPE-TRD" @default.
- Q90693429 P2899 "+18" @default.
- Q90693429 P3098 "NCT04338321" @default.
- Q90693429 P31 Q30612 @default.
- Q90693429 P4135 "+74" @default.
- Q90693429 P4844 Q186242 @default.
- Q90693429 P4844 Q2365493 @default.
- Q90693429 P4844 Q27108136 @default.
- Q90693429 P580 "2020-07-01T00:00:00Z" @default.
- Q90693429 P582 "2021-12-19T00:00:00Z" @default.
- Q90693429 P6099 Q42824827 @default.
- Q90693429 P8363 Q78089383 @default.